Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On Thursday 27th June 2019, the launch of the Oxford Centre for Early Cancer Detection (OxCODE) was celebrated with a symposium held at St Hilda’s College, Oxford.

The day consisted of talks highlighting Oxford’s existing strengths and future vision in early cancer detection research. The first session focused on Oxford’s innovative early cancer detection technologies, including Jason Davis’ bioelectrical assays, Deborah Goberdhan’s study of extracellular vesicles, Bethan Psaila’s single cell transcriptomic analysis, Chunxiao Song’s detection of epigenetic and genetic markers in cell-free DNA, Justin Benesch’s development of mass photometry and Hagan Bayley’s 3D-printed microtumours. In the second session on large cohort studies, Julia Hippisley-Cox described the use of the QCancer database for risk assessment and Ian Mills outlined his plans for enhanced early detection of clinically significant prostate cancers. The final session on digestive system cancers featured talks from Barbara Braden and Jens Rittscher on the use of artificial intelligence in endoscopic detection of oesophageal cancer, Simon Leedham on predicting risk in colitis-associated carcinogenesis and Ellie Barnes on the early detection of hepatocellular carcinoma. The successful day finished with a networking drinks reception.